Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Regulatory voting rights notification

Goldman Sachs crosses Evotec voting thresholds

Analysis based on 15 articles · First reported Aug 31, 2026 · Last updated Sep 08, 2026

Sentiment
0
Attention
1
Articles
15
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The announcements are routine regulatory disclosures and are unlikely to have a significant impact on Evotec's stock price or Goldman Sachs' operations. The slight changes in voting rights reflect normal portfolio adjustments by a major institutional investor.

Pharmaceuticals Financial Services

Goldman Sachs, Inc. has disclosed changes in its voting rights in Evotec SE, a German pharmaceutical company, through regulatory filings under the German Securities Trading Act (WpHG). On 24 August 2026, Goldman Sachs crossed a threshold, reporting total voting rights of 13.90% (0.07% shares and 13.83% through instruments). Subsequently, on 3 September 2026, another threshold was crossed, with total voting rights at 13.79% (0.43% shares and 13.36% through instruments). The notifications were made voluntarily at the subsidiary level and reflect adjustments in Goldman Sachs' holdings, including shares, convertible bonds, swaps, and other instruments. These filings are routine regulatory disclosures and do not indicate any change in control or strategic intent.

60 Goldman Sachs crossed voting threshold Evotec
stock
Evotec is the issuer subject to the voting rights notifications. The filings are routine and do not affect its operations or outlook.
Importance 100.0 Sentiment 0.0
stock
Goldman Sachs is the notifying shareholder, disclosing its voting rights in Evotec. The changes reflect its investment management activities and have no material impact on its business.
Importance 100.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.